Finzati - Logo
OLMA logo

Olema Pharmaceuticals, Inc.

OLMA • Biotechnology
$10.75
▲ +0.02 (+0.19%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.12B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 9.95Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 12, 2026, 12:13 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$10.75
Change0.19%
Shares Out104.45M
Market Cap$1.12B
Enterprise Value$662.47M
52W Range5.13 - 36.26
Beta2.01
P/E-5.49
P/B2.61
P/FCF-6.82
EV/EBITDA-3.05
EV/FCF-4.02

Investment DNA

How strong this company looks for long-term investors

42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
65/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 9.95Weak profitability

Analyst view

Analyst sentiment and price target

OLMA
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
100/100
Bullish
Bullish
8
Hold
0
Bearish
0
Price Target
2026-08-12
Low
$20.00
Mean
$31.00
Median
$35.00
High
$38.00

Company Overview

IPO: 11/19/2020
Industry: Biotechnology
P/B i: 2.61
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.00
Current Ratio: 9.95
Quick Ratio: 9.95
Status: Good

Insider Transactions

Recent executive and insider activity

Harmon Cyrus
Transaction: 07/24/2026
SELL
Change
-12,500
Price
$11.71
Filing
07/27/2026
Type
SELL
Harmon Cyrus
Transaction: 07/23/2026
SELL
Change
-12,500
Price
$11.58
Filing
07/27/2026
Type
SELL
Graham G. Walmsley
Transaction: 06/18/2026
BUY
Change
+29,500
Price
$9.51
Filing
06/23/2026
Type
BUY